Scienture Holdings, Inc. (SCNX NASDAQ) stock market data APIs
$3.8387
0.39(10.2%)
as of October 8, 2026
Try our APIs with
free plan!
Scienture Holdings, Inc. Financial Data Overview
Price chart is built with
Anychart
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.
Prev. Close
3.8387
Open
4.2281
High
4.296
Low
3.795
52 wk Range
3.23-65
Market Cap
6 784 K
Shares Outstanding
1 643 K
Revenue
821 K
EPS
-0.07
Beta
4.084
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Scienture Holdings, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Scienture Holdings, Inc. data using free add-ons & libraries
Get Scienture Holdings, Inc. Fundamental Data
Scienture Holdings, Inc. Fundamental data includes:
- Net Revenue: 821 K
- EBITDA: -12 361 262
- Earnings Per Share: -57
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Scienture Holdings, Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-13
- EPS/Forecast: -0.09
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Scienture Holdings, Inc. News
New
Scienture Holdings Q2 non-GAAP EPS of -$0.07, revenue of $0.34M
* Scienture Holdings, Inc. press release [https://seekingalpha.com/pr/20619685-scienture-reports-q2-2026-results-with-approximately-510-percent-sequential-revenue-growth] (SCNX [https://seekingalpha...
SCIENTURE Launches REZENOPY as Second FDA-Approved Commercial Product
Woman looking through microscope ©The U.S. National Archives SCIENTURE has commercially launched REZENOPY, its 10 mg naloxone nasal spray, and fulfilled initial purchase orders to U.S. pharmaceutica...
EXCLUSIVE: Scienture Launches Highest-Dose Naloxone Nasal Spray Rezenopy in US
Pharmaceutical firm Scienture Holdings, Inc.(NASDAQ:SCNX) on Wednesday officially initiated the commercial rollout of Rezenopy, a 10-milligram naloxone hydrochloride nasal spray. The company has succ...
Scienture Announces Commercial Inventory Readiness For REZENOPY Naloxone Nasal Spray; Stock Up
(RTTNews) - Scienture Holdings, Inc. (SCNX) announced that it has completed manufacturing of commercial launch inventory and will begin shipments in July of REZENOPY Nasal Spray 10 mg to U.S. pharmace...
Get Scienture Holdings, Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.